TUSC3 promotes colorectal cancer progression and epithelial-mesenchymal transition (EMT) through WNT/β-catenin and MAPK signalling
- 28 March 2016
- journal article
- Published by Wiley in The Journal of Pathology
- Vol. 239 (1), 60-71
- https://doi.org/10.1002/path.4697
Abstract
Colorectal cancer (CRC) is one of the most common malignancies and is the second leading cause of cancer death in humans. Tumour suppressor candidate 3 (TUSC3) plays an important role in embryogenesis and metabolism. Deletion of TUSC3 often causes non-syndromic mental retardation. Even though TUSC3 deregulation is frequently observed in epithelial cancers, the function of TUSC3 in CRC has remained unknown. In this study, we observed greater expression of TUSC3 at the mRNA and protein level in clinical colorectal tumour samples compared with paired normal tissues. Gain- and loss-of-function analyses were performed to evaluate the functional significance of TUSC3 in CRC initiation and progression. Immunoblotting, immunofluorescence, and co-immunoprecipitation analyses were used to identify potential pathways with which TUSC3 might be involved. Overexpression of TUSC3 in CRC cells induced epithelial-mesenchymal transition (EMT) in CRC cells, accompanied by down-regulation of the epithelial marker, E-cadherin, and up-regulation of the mesenchymal marker, vimentin. Increased proliferation, migration, and invasion, as well as accelerated xenograft tumour growth, were observed in TUSC3-overexpressing CRC cells, while opposite effects were achieved in TUSC3-silenced cells. In conclusion, our study demonstrated the oncogenic role of TUSC3 in CRC and showed that TUSC3 may be responsible for alternations in the proliferation ability, aggressiveness, and invasive/metastatic potential of CRC through regulating the MAPK, PI3K/Akt, and Wnt/β-catenin signalling pathways. Copyright © 2016 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.Funding Information
- National Basic Research Program of China (2015CB554002)
- NSFC-Guangdong Joint Fund (U1201226)
- National Natural Science Foundation of China (81472313, 81071735)
- Guangdong Provincial Natural Science Foundation of China (S2012010009643)
- Science and Technology Innovation Foundation of Guangdong Higher Education (CXZD1016)
- Key Program of the National Natural Science Foundation of Guangdong (2010B031500012)
- Guangzhou Science & Technology plan project (201300000056)
- Pearl River Nova Program of Guangzhou City (2012J2200044)
This publication has 38 references indexed in Scilit:
- Methylation status of TUSC3 is a prognostic factor in ovarian cancerCancer, 2012
- Gene expression profiling of papillary thyroid carcinomas in Korean patients by oligonucleotide microarraysJournal of the Korean Surgical Society, 2012
- Oligosaccharyltransferase: the central enzyme of N‐linked protein glycosylationJournal of Inherited Metabolic Disease, 2011
- A novel deletion mutation in the TUSC3 gene in a consanguineous Pakistani family with autosomal recessive nonsyndromic intellectual disabilityBMC Medical Genetics, 2011
- Guidelines for the welfare and use of animals in cancer researchBritish Journal of Cancer, 2010
- Mammalian MagT1 and TUSC3 are required for cellular magnesium uptake and vertebrate embryonic developmentProceedings of the National Academy of Sciences of the United States of America, 2009
- A Defect in the TUSC3 Gene Is Associated with Autosomal Recessive Mental RetardationAmerican Journal of Human Genetics, 2008
- Aberrant methylation of p16, HIC1, N33, and GSTP1 in tumor epithelium and tumor-associated cells in prostate cancerMolecular Biology, 2007
- Glycogen synthase kinase-3 is an endogenous inhibitor of Snail transcriptionThe Journal of cell biology, 2005
- Detection of disseminated tumour cells in bone marrow of patients with isolated liver metastases from colorectal cancerJournal of Surgical Oncology, 2003